Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,17 € ↓ -0,02 (-0,39%)
2026-06-04
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionJacobs Levy Equity Management, Inc
Latest Disclosed Ownership1,168,681 shares
Latest Disclosed Value $ 8,075,586
Jacobs Levy Equity Management, Inc reports 64.97% increase in ownership of VM4 / Vanda Pharmaceuticals Inc.

On May 15, 2026 - Jacobs Levy Equity Management, Inc filed a 13F-HR form disclosing ownership of 1,168,681 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $6,719,916 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 708,428 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of 64.97% during the quarter. The current value of the position is $6,042,081 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,168,681 460,253 64.97 8,076 29.24 0.0339
2026-02-13 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 708,428 599,818 552.27 6,248 1,054.90 0.0241
2025-11-17 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 108,610 -57,383 -34.57 542 -30.91 0.0022
2025-08-14 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 165,993 -108,300 -39.48 783 -37.81 0.0031
2025-05-15 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 274,293 -196,433 -41.73 1,259 -44.14 0.0050
2025-02-14 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 470,726 -959,807 -67.09 2,255 -66.40 0.0080
2024-11-14 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,430,533 -55,729 -3.75 6,709 -20.10 0.0259
2024-08-14 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,486,262 66,702 4.70 8,397 43.93 0.0347
2024-05-15 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,419,560 -10,290 -0.72 5,834 -3.30 0.0261
2024-02-14 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,429,850 463,994 48.04 6,034 44.61 0.0304
2023-11-17 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 965,856 156,896 19.39 4,172 -21.74 0.0247
2023-08-14 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 808,960 -87,547 -9.77 5,331 -12.42 0.0307
2023-05-15 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 896,507 46,162 5.43 6,087 -3.13 0.0373
2023-02-14 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 850,345 -5,625 -0.66 6,284 -25.69 0.0425
2022-11-15 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 855,970 -175,525 -17.02 8,457 -24.78 0.0669
2022-08-15 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,031,495 950,812 1,178.45 11,243 1,131.43 0.0870
2022-05-16 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 80,683 80,683 913 0.0061
2022-02-14 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 0 -87,493 -100.00 0 -100.00
2021-11-15 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 87,493 -134,141 -60.52 1,500 -68.53 0.0101
2021-08-16 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 221,634 -486,854 -68.72 4,767 -55.20 0.0323
2021-05-17 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 708,488 -42,951 -5.72 10,641 7.77 0.0821
2021-02-16 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 751,439 303,295 67.68 9,874 128.09 0.0866
2020-11-16 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 448,144 448,144 4,329 0.0449
2019-08-13 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 0 -12,900 -100.00 0 -100.00
2019-05-14 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 12,900 -84,635 -86.77 237 -90.70 0.0034
2019-02-14 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 97,535 61,910 173.78 2,549 211.61 0.0448
2018-11-14 2018-09-30 13F VANDA PHARMACEUTICALS COM 921659108 35,625 -5,675 -13.74 818 3.94 0.0116
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 41,300 6,410 18.37 787 33.84 0.0124
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 34,890 12,400 55.14 588 71.93 0.0098
2018-02-13 2017-12-31 13F VANDA PHARMACEUTICALS COM 921659108 22,490 22,490 342 0.0060
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.